Form 483

Gland Pharma Limited Form 483, 2023-08-26

FDA issued a Form 483 to Gland Pharma Limited on 2023-08-26 with 2 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health2 observations

Gland Pharma Limited · Sangareddy district, Hyderabad, India · Issued August 26, 2023

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Aug 2023
21 CFR 820.186

QSR

Cited by Dipesh K Shah

26 Aug 2023
21 CFR 820.70(g)

Equipment Installation, Placement, Specified Requirements

Cited by Dipesh K Shah

Inspected site

GPGland Pharma LimitedSangareddy district, Hyderabad, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.186Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere